Globe Newswire
Dublin, Jan. 21, 2021 (GLOBE NEWSWIRE) -- The "Biosimilar Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" report has been added to ResearchAndMarkets.com's offering. This report on the global biosimilar market provides qualitative and quantitative analysis for the period from 2018 to 2026. The report predicts the global biosimilar market to grow with a CAGR of 35.12% over the forecast period from 2020-2026. The study on biosimilar market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2018 to 2026.The report on biosimilar market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global biosimilar market over the period of 2018 to 2026. Moreover, the report is a collective presentation of primary and secondary research findings.Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global biosimilar market over the period of 2018 to 2026. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.Report Findings1) Drivers Growing number of geriatric population and increasing awareness about biosimilar among the patients and doctorsIncreasing number of patients with chronic illnesses such as diabetes and cancer 2) Restraints The high manufacturing cost and complexity of production are expected to be the major restraints 3) Opportunities The expiry of patents of various blockbuster drugs is a major factor for the growth Research MethodologyA) Primary ResearchThe primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include1. Key Opinion Leaders2. Internal and External subject matter experts3. Professionals and participants from the industryThe primary research respondents typically include1. Executives working with leading companies in the market under review2. Product/brand/marketing managers3. CXO level executives4. Regional/zonal/ country managers5. Vice President level executives.B) Secondary ResearchSecondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.The secondary sources of the data typically include1. Company reports and publications2. Government/institutional publications3. Trade and associations journals4. Databases such as WTO, OECD, World Bank, and among others.5. Websites and publications by research agenciesSegment CoveredThe global biosimilar market is segmented on the basis of product, and application.The Global Biosimilar Market by Product Human Growth HormonesMonoclonal AntibodiesInsulinPeptidesErythropoietinOther Products The Global Biosimilar Market by Application OncologyChronic and Autoimmune DiseasesGrowth Hormone DeficiencyInfectious DiseasesOther Applications What does this Report Deliver?1. Comprehensive analysis of the global as well as regional markets of the biosimilar market.2. Complete coverage of all the segments in the biosimilar market to analyze the trends, developments in the global market and forecast of market size up to 2026.3. Comprehensive analysis of the companies operating in the global biosimilar market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify. Key Topics Covered: 1. Preface1.1. Report Description1.2. Research Methods1.3. Research Approaches2. Executive Summary2.1. Biosimilar Market Highlights2.2. Biosimilar Market Projection2.3. Biosimilar Market Regional Highlights3. Global Biosimilar Market Overview3.1. Introduction3.2. Market Dynamics3.2.1. Drivers3.2.2. Restraints3.2.3. Opportunities3.3. Analysis of COVID-19 impact on the Biosimilar Market3.4. Porter's Five Forces Analysis3.5. Growth Matrix Analysis3.5.1. Growth Matrix Analysis by Product3.5.2. Growth Matrix Analysis by Application 3.5.3. Growth Matrix Analysis by Region3.6. Value Chain Analysis of Biosimilar Market4. Biosimilar Market Macro Indicator Analysis5. Global Biosimilar Market by Product5.1. Human Growth Hormones5.2. Monoclonal Antibodies5.3. Insulin5.4. Peptides5.5. Erythropoietin5.6. Other Products6. Global Biosimilar Market by Application 6.1. Oncology6.2. Chronic and Autoimmune Diseases6.3. Growth Hormone Deficiency6.4. Infectious Diseases6.5. Other Applications7. Global Biosimilar Market by Region 2020-20267.1. North America 7.1.1. North America Biosimilar Market by Product7.1.2. North America Biosimilar Market by Application7.1.3. North America Biosimilar Market by Country7.2. Europe 7.2.1. Europe Biosimilar Market by Product7.2.2. Europe Biosimilar Market by Application7.2.3. Europe Biosimilar Market by Country7.3. Asia-Pacific 7.3.1. Asia-Pacific Biosimilar Market by Product7.3.2. Asia-Pacific Biosimilar Market by Application7.3.3. Asia-Pacific Biosimilar Market by Country7.4. RoW 7.4.1. RoW Biosimilar Market by Product7.4.2. RoW Biosimilar Market by Application7.4.3. RoW Biosimilar Market by Sub-region8. Company Profiles and Competitive Landscape8.1. Competitive Landscape in the Global Biosimilar Market8.2. Companies Profiled8.2.1. Allergan plc8.2.2. BIOCAD8.2.3. Biocon Limited8.2.4. BioXpress Therapeutics SA8.2.5. Boehringer Ingelheim International GmbH8.2.6. Celltrion Inc8.2.7. Coherus BioSciences, Inc8.2.8. Dr. Reddy's Laboratories Ltd8.2.9. Genor BioPharma Co. Ltd8.2.10. Novartis AG For more information about this report visit https://www.researchandmarkets.com/r/wtnxpp CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900